Results

Total Results: 437 records

Showing results for "therapeutic".

101. Appendix B. Clinical Materials to Share With Primary Care Providers | Agency for Healthcare Research and Quality
     www.ahrq.gov/patient-safety/settings/hospital/resource/nicu/packet/apb.html
     December 01, 2013 - Caffeine is most commonly used due to its broader therapeutic index and slower excretion rate than theophylline … important to distinguish between physiologic and pathologic GER (GERD, or GER disease) before beginning any therapeutic … Treatment Medical or surgical therapy is indicated only for pathological GER. … Therapies may improve symptoms, but generally reflux is not entirely eliminated. … Surgical Treatments Goals of surgery: Slow intestinal transit.

102. Final Progress Report: Off-Label Prescribing: Comparative Evidence, Regulation, and Utilization (pdf file)
     www.ahrq.gov/sites/default/files/2024-01/kesselheim-report.pdf
     January 01, 2024 - Off-label drug use thus involves prescriptions that may or may not be sound therapy, that may involve … When available treatments were limited, patients or their caregivers felt that they had to take whatever … therapy. … Clinical Pharmacology and Therapeutics 2012;92(6):694. 35. … Clinical Pharmacology and Therapeutics 2015 [in press] 46.

103. Final Progress Report: Risk-Informed Intervention to Improve Ambulatory Drug Monitoring and Safety (pdf file)
     www.ahrq.gov/sites/default/files/2024-01/field-report.pdf
     January 01, 2024 - improve patient safety by implementing interventions to improve the rate of ordering and completion of therapeutic … safety by implementing an intervention directed at improving the rate of ordering and completion of therapeutic … the safe use of medications requires identification of additional effective approaches to increasing therapeutic … Patient adherence to laboratory tests to monitor medication therapy: a mixed-methods study. … Frequency of serum creatinine monitoring during allopurinol therapy in ambulatory patients.

104. National Action Alliance Webinar: Engineering Safety into Practice Through Implementation of the 2025 SAFER Guides Chat Conversations, January 21, 2025 (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/action-alliance/safer-guides-webinar-chat.pdf
     February 18, 2025 - from Heather Sherman to everyone: 12:23 PM By consent, do you mean "informed consent" in the therapeutic

105. Measure: Thermal Condition of Low Birth Weight Neonates Admitted to Level 2 or Higher Nurseries in the First 24 Hours of Life (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/chipra-1416-p006-2-ef.pdf
     December 01, 2015 - comfort care, neonates with anencephaly; and/or optional: Neonates managed with hypothermia for therapeutic

106. Final Progress Report: Optimal Prevention of Hospital-Acquired Venous Thromboembolism (pdf file)
     www.ahrq.gov/sites/default/files/2024-02/maynard-report.pdf
     January 01, 2024 - nurse practitioner targeted serial patients on the list for additional study, excluding patients on therapeutic … Finally, we asked nurses to evaluate patients who were not on therapeutic or prophylactic doses of anticoagulants … a more accurate and timely chart review and allows for near real time feedback to the responsible treatment … ward location, could be merged with a pharmacy-generated listing of patients on any prophylactic or therapeutic … conference on antithrombotic and thrombolytic therapy.

107. Final Progress Report: Improving Medication Safety Across Clinical Settings (pdf file)
     www.ahrq.gov/sites/default/files/2024-01/bates-report.pdf
     January 01, 2024 - Scope of Work: Background: The pharmacologic treatment of psychiatric disorders has improved tremendously … Consistently subtherapeutic INR levels (at least three consecutive values < 1.5 over several weeks of treatment … ) were also considered to be potential adverse drug events when the appropriate therapeutic range for … There were 490 who received warfarin therapy. … “Variability in Intravenous Infusion Therapy.”

108. Final Progress Report: Show Your Work: Do Prescription Annotations Impact Near-miss Medication Errors? (pdf file)
     www.ahrq.gov/sites/default/files/2024-01/johnson-baughman-report.pdf
     January 01, 2024 - In their study, for example, the rate at which therapeutic goals were achieved increased from 74% to … Insurance-related callbacks Need to Change Medication: Not Covered 20 3.97% Prior Authorization Needed 48 9.52% Therapeutic … Quality assessment of a collaborative approach for decreasing drug-related morbidity and achieving therapeutic

109. Treating Tobacco Use and Dependence, 2008 Update: References for Studies in Meta-analyses (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/clinicians-providers/guidelines-recommendations/tobacco/clinicians/references/meta/meta-analyses-refs.pdf
     January 01, 2007 - Evaluation of a treatment approach combining nicotine gum with self-guided behavioral treatments for … Mood management and nicotine gum in smoking treatment: a therapeutic contact and placebo- controlled … Mood management and nicotine gum in smoking treatment: a therapeutic contact and placebo- controlled … Mood management and nicotine gum in smoking treatment: a therapeutic contact and placebo- controlled … Mood management and nicotine gum in smoking treatment: a therapeutic contact and placebo- controlled

110. Medication Management | Agency for Healthcare Research and Quality
     www.ahrq.gov/patient-safety/reports/engage/interventions/medmanage-slides.html
     May 01, 2017 - Diagnosis and treatment. Fragmentation and environment of care. … interactions with other medications or over the counter medicines Overdoses Appropriateness as a treatment … Therapeutic Drug Use. [updated 2016 July 6; cited 2016 Aug 1].

111. Imbedding Research in Practice to Improve Medication Safety (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol4/Advances-Raebel_53.pdf
     May 07, 2008 - prescribed critically interacting drugs (Critical Drug Interactions); (2) receive anticoagulation treatment … During ongoing therapy: • N = 9,139 patients received prescriptions for ongoing therapy with any of … States Food and Drug Administration (FDA) pregnancy risk category D (i.e., evidence of fetal risk; therapeutic … outweigh the risk) or category X (i.e., evidence suggests that the risk to the fetus outweighs the therapeutic … Note: If therapeutic equivalent drug substitution for amitriptyline is authorized by the RDCs in the

112. Introduction to Synthetic Healthcare Database for Research (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/data/SyH-DR-Introduction-2023Dec.pdf
     December 01, 2023 - procedures beyond the Clinical Classifications Software category level, and rare drugs beyond the therapeutic … RX No No No Generic Drug Name Generic_Drug_Name RX No Partial, assigned name in the same Multum Therapeutic

113. CHIPRA 213: Section 5, Table 4 (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-213-section-5-table-4.pdf
     January 01, 2012 - Anemia (MSH), a randomized, double‐ blind, placebo‐controlled clinical trial, found that hydroxyurea therapy … Finally, no adverse effect on growth was observed during the treatment period. … guidelines (from agencies or groups) NHLBI guidelines suggest that indications for hydroxyurea therapy … Hydroxyurea also decreases leukocyte count, and releases nitric oxide. … Hydroxyurea may be an ideal therapeutic … Clinical guidelines “Indications for hydroxyurea therapy are not universally agreed upon, but with

114. Session 2 | Agency for Healthcare Research and Quality
     www.ahrq.gov/patient-safety/settings/long-term-care/resource/facilities/ltc/mod2sess2.html
     October 01, 2014 - For instance, you may say "I think he may have had a stroke." or "Her Coumadin is well above the therapeutic

115. Designing & Delivering Whole-Person Transitional Care The Hospital Guide to Reducing Medicaid Readmissions Webinar 3
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/medicaidreadmitguide/aspire_webinar3/aspire_webinar3.pptx
     December 01, 2014 - consisting of a : Center Director, Registered Nurse, Licensed Social Worker, Dietician, CNA , GNA, CMA , and Therapeutic

116. Pediatric Patient Safety Consortium (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA202-Materials_XIII.pdf
     January 01, 2014 - Coulter, MD Referred by AAP Section on Neurology Therapies (OT/PT/Speech) Amy Houtrow, MD, MPH … through services and therapies provided from birth through 3 years of age. …  Physical Therapy  Occupational Therapy  Medical Home Provider Internal  Specialty Provider …  Physical Therapy  Occupational Therapy  Medical Home Provider Internal  Specialty Provider … Is there a significant therapeutic distinction compared to existing coded treatments or products?

117. Pediatric Patient Safety Consortium (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA205-Materials_XIII.pdf
     August 13, 2014 - Coulter, MD Referred by AAP Section on Neurology Therapies (OT/PT/Speech) Amy Houtrow, MD, MPH … through services and therapies provided from birth through 3 years of age. …  Physical Therapy  Occupational Therapy  Medical Home Provider Internal  Specialty Provider …  Physical Therapy  Occupational Therapy  Medical Home Provider Internal  Specialty Provider … Is there a significant therapeutic distinction compared to existing coded treatments or products?

118. Pediatric Patient Safety Consortium (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA204-Materials_XIII.pdf
     August 25, 2014 - Coulter, MD Referred by AAP Section on Neurology Therapies (OT/PT/Speech) Amy Houtrow, MD, MPH … through services and therapies provided from birth through 3 years of age. …  Physical Therapy  Occupational Therapy  Medical Home Provider Internal  Specialty Provider …  Physical Therapy  Occupational Therapy  Medical Home Provider Internal  Specialty Provider … Is there a significant therapeutic distinction compared to existing coded treatments or products?

119. Final Progress Report: Clinical importance of the drug interaction between statins and CYP3A inhibitors (pdf file)
     www.ahrq.gov/sites/default/files/2024-01/strom-report.pdf
     January 01, 2024 - To depict each patient's current health status, physician care, and concomitant therapies, laboratory … Clinical Therapeutics. Aug 2007;29(8):1761-1770. 5. … A systematic review and meta-analysis on the therapeutic equivalence of statins. … Estimating Causal Effects of Treatments in Randomized and Nonrandomized Studies. … Clinical Pharmacology & Therapeutics. Mar 1998;63(3):332-341. 55.

120. Apcd-Inventory (xls file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/quality-resources/apcd/apcd-inventory.xlsx
     October 01, 2015 - No Cardiac Coronary artery disease (CAD) Quality Process Adherence to Statin Therapy for Individuals … No Cardiac AMI Quality Process Post MI: ACE Inhibitor or ARB Therapy [ACE = angiotensin-converting enzyme … No Cardiac Percutaneous coronary intervention (PCI) Quality Process Adherence to Antiplatelet Therapy … No Cross-cutting Physical Therapy Cost Not applicable Physical Therapy NA FAIR Health http://fairhealthconsumer.org … No Kidney or bladder disorders Stone Cost, Utilization Not applicable Medical expulsive therapy versus